Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
NCT ID: NCT05076110
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
188 participants
INTERVENTIONAL
2022-04-07
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hip Arthroscopy Postoperative Opioid Demands
NCT04094701
Efficacy of Multimodal Analgesia Following Hip Arthroscopy
NCT03351439
Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement
NCT03119038
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
NCT03858231
Postoperative Pain Treatment in Total Hip Arthroplasty: A Study to Assess the Effect of Local Analgesia
NCT00603083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care Group
Subjects will receive standard of care pain medication Oxycodone for pain control following hip arthroscopy procedure
Oxycodone
5 mg tablets every 4 hours postoperatively as needed for pain control
Non-Opiate Pain Control Group
Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Ibuprofen
800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day
Gabapentin
300 mg three times a day for 5 days then wean off by day 10 postoperatively
Acetaminophen
1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day
Methocarbamol
500 mg three times a week for 2 weeks postoperatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxycodone
5 mg tablets every 4 hours postoperatively as needed for pain control
Ibuprofen
800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day
Gabapentin
300 mg three times a day for 5 days then wean off by day 10 postoperatively
Acetaminophen
1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day
Methocarbamol
500 mg three times a week for 2 weeks postoperatively
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Substantial alcohol or drug abuse.
* History of narcotics within 6 months of surgery.
* Pregnancy.
* Renal impairment.
* Peptic ulcer disease.
* GI bleeding.
16 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kelechi R. Okoroha
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelechi Okoroha, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-003441
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.